Hello. Sign in to personalize your visit. New user? Register now.  
Human Gene Therapy
Highly Purified Recombinant Adeno-Associated Virus Vectors Are Biologically Active and Free of Detectable Helper and Wild-Type Viruses
To cite this article:
K. Reed Clark, Xinglou Liu, John P. Mcgrath, Philip R. Johnson. Human Gene Therapy. April 1999, 10(6): 1031-1039. doi:10.1089/10430349950018427.
Full Text: • PDF for printing (334.4 KB) • PDF w/ links (337 KB)


K. Reed Clark,
Xinglou Liu,
John P. Mcgrath,
Philip R. Johnson

Gene transfer vectors based on the replication-defective human parvovirus, adeno-associated virus type 2 (AAV-2), are viable candidates for in vivo and ex vivo human use. However, widespread testing of AAV vectors has been limited by difficulties in generating pure, high-titer vector stocks that are fully characterized. To address these issues, we have developed a single-step purification scheme using heparin affinity chromatography. Recovery from the crude lysate starting material exceeds 70%, and the end product rAAV vector is highly purified and appears to be free of adenovirus and cellular contaminates. Importantly, purified vectors retain predicted in vivo biologic activity. Concurrently, we have developed simple and rapid approaches for vector quantification using real-time PCR. These new methods, combined with the use of stable producer cell lines for rAAV production, make the commercial production of rAAV vectors for human use truly viable and pragmatic.

Free first page

This paper was cited by:

A Simplified Baculovirus-AAV Expression Vector System Coupled With One-step Affinity Purification Yields High-titer rAAV Stocks From Insect Cells
Richard H Smith, Justin R Levy, Robert M Kotin
Molecular Therapy. Jul 2009
CrossRef
Transient Transfection Methods for Clinical Adeno-Associated Viral Vector Production
J. Fraser Wright
Human Gene Therapy. Jul 2009, Vol. 20, No. 7: 698-706
Abstract | Full Text PDF | Reprints & Permissions
Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice
Matthew Giannandrea, Robert H. Pierce, Ian Nicholas Crispe
Hepatology. Jul 2009, Vol. 49, No. 6: 2010-2020
CrossRef
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
Philip R Johnson, Bruce C Schnepp, Jianchao Zhang, Mary J Connell, Sean M Greene, Eloisa Yuste, Ronald C Desrosiers, K Reed Clark
Nature Medicine. Jun 2009
CrossRef
Genetic Vaccines for Anthrax Based on Recombinant Adeno-associated Virus Vectors
Te-Hui Liu, Jon Oscherwitz, Bruce Schnepp, Jana Jacobs, Fen Yu, Kemp B Cease, Philip R Johnson
Molecular Therapy. Mar 2009, Vol. 17, No. 2: 373-379
CrossRef
Site-specific Modification of AAV Vector Particles With Biophysical Probes and Targeting Ligands Using Biotin Ligase
Matthew D Stachler, Irwin Chen, Alice Y Ting, Jeffrey S Bartlett
Molecular Therapy. Sep 2008, Vol. 16, No. 8: 1467-1473
CrossRef
Manufacturing and characterizing AAV-based vectors for use in clinical studies
J F Wright
Gene Therapy. Jul 2008, Vol. 15, No. 11: 840-848
CrossRef
Toward exascale production of recombinant adeno-associated virus for gene transfer applications
S Cecchini, A Negrete, R M Kotin
Gene Therapy. Jul 2008, Vol. 15, No. 11: 823-830
CrossRef
Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8
M Natkunarajah, P Trittibach, J McIntosh, Y Duran, S E Barker, A J Smith, A C Nathwani, R R Ali
Gene Therapy. Apr 2008, Vol. 15, No. 6: 463-467
CrossRef
Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA B receptors in scopolamine-induced amnesia
Jonathan Brouillette, Deborah Young, Matthew J. During, Rémi Quirion
Journal of Neurochemistry. Oct 2007, Vol. 102, No. 6: 1978-1989
CrossRef
Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus
Joshua N. Leonard, Peter Ferstl, Antonio Delgado, David V. Schaffer
Biotechnology and Bioengineering. Sep 2007, Vol. 97, No. 5: 1170-1179
CrossRef
Protection Against Cisplatin-Induced Ototoxicity by Adeno-Associated Virus-Mediated Delivery of the X-Linked Inhibitor of Apoptosis Protein Is Not Dependent on Caspase Inhibition
Dylan K. Chan, David M. Lieberman, Sergei Musatov, Joshua A. Goldfein, Samuel H. Selesnick, Michael G. Kaplitt
Otology & Neurotology. May 2007, Vol. 28, No. 3: 417-425
CrossRef
Engineering Adeno-Associated Virus for One-Step Purification via Immobilized Metal Affinity Chromatography
James T. Koerber, Jae-Hyung Jang, Julie H. Yu, Ravi S. Kane, David V. Schaffer
Human Gene Therapy. Apr 2007, Vol. 18, No. 4: 367-378
Abstract | Full Text PDF | Reprints & Permissions
Gene Transfer to the Gastrointestinal Tract After Peroral Administration of Recombinant Adeno-associated Virus Type 2 Vectors
Guohong Shao, Kristin Greathouse, Qin Huang, Chiou-Miin Wang, Thomas J. Sferra
Journal of Pediatric Gastroenterology and Nutrition. Sep 2006, Vol. 43, No. 2: 168-179
CrossRef
Novel role for aspartoacylase in regulation of BDNF and timing of postnatal oligodendrogenesis
Jeremy S. Francis, Ana Olariu, Scott W. McPhee, Paola Leone
Journal of Neuroscience Research. Aug 2006, Vol. 84, No. 1: 151-169
CrossRef
Gene-Eluting Stents: Comparison of Adenoviral and Adeno- Associated Viral Gene Delivery to the Blood Vessel Wall In Vivo
Faisal Sharif, Sean O. Hynes, Jill McMahon, Ronan Cooney, Siobhan Conroy, Peter Dockery, Garry Duffy, Kieran Daly, James Crowley, Jeffrey S. Bartlett, Timothy O'brien
Human Gene Therapy. Jul 2006, Vol. 0, No. 0: 060801084750030
CrossRef
Gene-Eluting Stents: Comparison of Adenoviral and Adeno- Associated Viral Gene Delivery to the Blood Vessel Wall In Vivo
Faisal Sharif, Sean O. Hynes, Jill McMahon, Ronan Cooney, Siobhan Conroy, Peter Dockery, Garry Duffy, Kieran Daly, James Crowley, Jeffrey S. Bartlett, Timothy O'Brien
Human Gene Therapy. Jul 2006, Vol. 17, No. 7: 741-750
Abstract | Full Text PDF | Reprints & Permissions
AAV-Mediated Delivery of the Caspase Inhibitor XIAP Protects Against Cisplatin Ototoxicity
Louis B. Cooper, Dylan K. Chan, Frederick C. Roediger, Brian R. Shaffer, Justin F. Fraser, Sergei Musatov, Samuel H. Selesnick, Michael G. Kaplitt
Otology & Neurotology. Jul 2006, Vol. 27, No. 4: 484-490
CrossRef
Homer Isoforms Differentially Regulate Cocaine-Induced Neuroplasticity
Karen K Szumlinski, Kenneth E Abernathy, Erik B Oleson, Matthias Klugmann, Kevin D Lominac, Dao-Yao He, Dorit Ron, Matthew During, Peter W Kalivas
Neuropsychopharmacology. May 2006, Vol. 31, No. 4: 768-777
CrossRef
Differential Actions of NPY on Seizure Modulation via Y1 and Y2 Receptors: Evidence from Receptor Knockout Mice
En-Ju Deborah Lin, Deborah Young, Kristin Baer, Herbert Herzog, Matthew J. During
Epilepsia. May 2006, Vol. 47, No. 4: 773-780
CrossRef
Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells
M D Stachler, J S Bartlett
Gene Therapy. Mar 2006
CrossRef
Insertional Mutagenesis at Positions 520 and 584 of Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Generation of AAV2 Vectors with Eliminated Heparin- Binding Ability and Introduced Novel Tropism
Xiangqun Shi, Guangguang Fang, Wenfang Shi, Jeffrey S. Bartlett
Human Gene Therapy. Mar 2006, Vol. 17, No. 3: 353-361
Abstract | Full Text PDF | Reprints & Permissions
Insertional Mutagenesis at Positions 520 and 584 of Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Generation of AAV2 Vectors with Eliminated Heparin-Binding Ability and Introduced Novel Tropism
Xiangqun Shi, Guangguang Fang, Wenfang Shi
Human Gene Therapy. Feb 2006, Vol. 0, No. 0: 060123080936001
CrossRef
Current issues in adeno-associated viral vector production
O-W Merten, C Gény-Fiamma, A M Douar
Gene Therapy. Nov 2005, Vol. 12: S51-S61
CrossRef
Downstream processing of viral vectors and vaccines
R Morenweiser
Gene Therapy. Nov 2005, Vol. 12: S103-S110
CrossRef
Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications
E Burova, E Ioffe
Gene Therapy. Nov 2005, Vol. 12: S5-S17
CrossRef
Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniques
A M Duffy, A M O'Doherty, T O'Brien, P M Strappe
Gene Therapy. Nov 2005, Vol. 12: S62-S72
CrossRef
Activity-dependent subcellular localization of NAC1
Laxman Korutla, Nicholas Champtiaux, Hao-Wei Shen, Matthias Klugman, Peter W. Kalivas, Scott A. Mackler
European Journal of Neuroscience. Aug 2005, Vol. 22, No. 2: 397-403
CrossRef
Production of Recombinant Adeno-Associated Virus Vectors
S. Zolotukhin
Human Gene Therapy. May 2005, Vol. 16, No. 5: 551-557
Abstract | Full Text PDF | Reprints & Permissions
Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components
Satoki Nakamura, Reiko Nakamura, Kiyoshi Shibata, Miki Kobayashi, Naohi Sahara, Kazuyuki Shigeno, Kaori Shinjo, Kensuke Naito, Kazunori Ohnishi, Noriyuki Kasahara, Yuichi Iwaki
European Journal of Haematology. Nov 2004, Vol. 73, No. 4: 285-294
CrossRef
Infectious Titer Assay for Adeno-Associated Virus Vectors with Sensitivity Sufficient to Detect Single Infectious Events
Zhu Zhen, Yero Espinoza, Thieu Bleu, Jürg M. Sommer, J. Fraser Wright
Human Gene Therapy. Jul 2004, Vol. 15, No. 7: 709-715
Abstract | Full Text PDF | Reprints & Permissions
Recombinant Adeno-Associated Virus As Delivery Vector for Gene Therapy—A Review
Yang Lu
Stem Cells and Development. Feb 2004, Vol. 13, No. 1: 133-145
Abstract | Full Text PDF | Reprints & Permissions
Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development
En-Ju D. Lin, Cristina Richichi, Deborah Young, Kristin Baer, Annamaria Vezzani, Matthew J. During
European Journal of Neuroscience. Nov 2003, Vol. 18, No. 7: 2087-2092
CrossRef
Efficiencies of Transgene Expression in Nociceptive Neurons Through Different Routes of Delivery of Adeno-Associated Viral Vectors
Ya Xu, Yanping Gu, Ping Wu, Guang-Wen Li, Li-Yen Mae Huang
Human Gene Therapy. Jun 2003, Vol. 14, No. 9: 897-906
Abstract | Full Text PDF | Reprints & Permissions
Gene therapy and tissue engineering in repair of the musculoskeletal system
Daniel Wu, Pasquale Razzano, Daniel A. Grande
Journal of Cellular Biochemistry. Mar 2003, Vol. 88, No. 3: 467-481
CrossRef
Recombinant Adeno-Associated Virus Vectors Efficiently and Persistently Transduce Chondrocytes in Normal and Osteoarthritic Human Articular Cartilage
Henning Madry, Magali Cucchiarini, Ernest F. Terwilliger, Stephen B. Trippel1
Human Gene Therapy. Mar 2003, Vol. 14, No. 4: 393-402
Abstract | Full Text PDF | Reprints & Permissions
Scalable Purification of Adeno-Associated Virus Type 2, 4, or 5 Using Ion-Exchange Chromatography
Nikola Kaludov, Beverly Handelman, John A. Chiorini
Human Gene Therapy. Jul 2002, Vol. 13, No. 10: 1235-1243
Abstract | Full Text PDF | Reprints & Permissions
Recent advances in recombinant adeno-associated virus vector production
K. Reed Clark
Kidney International. Feb 2002, Vol. 61, No. s1: 9-15
CrossRef
Tightly Regulated Long-Term Erythropoietin Expression In Vivo Using Tet-Inducible Recombinant Adeno-Associated Viral Vectors
Katherine G. Rendahl, Dulce Quiroz, Martha Ladner, Mazie Coyne, Jon Seltzer, William C. Manning, Jaime A. Escobedo
Human Gene Therapy. Jan 2002, Vol. 13, No. 2: 335-342
Abstract | Full Text PDF | Reprints & Permissions
GENE THERAPY: Promises and Problems
Alexander Pfeifer, Inder M. Verma
Annual Review of Genomics and Human Genetics. Oct 2001, Vol. 2, No. 1: 177-211
CrossRef
Insertional Mutagenesis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Generation of AAV2 Vectors Targeted to Alternative Cell-Surface Receptors
Wenfang Shi, Gregory S. Arnold, Jeffrey S. Bartlett
Human Gene Therapy. Sep 2001, Vol. 12, No. 14: 1697-1711
Abstract | Full Text PDF | Reprints & Permissions
Concentration of viral vectors by co-precipitation with calcium phosphate
Linh Pham, Hong Ye, Francois-Loic Cosset, Stephen J. Russell, Kah-Whye Peng
The Journal of Gene Medicine. Apr 2001, Vol. 3, No. 2: 188-194
CrossRef
Optimised helper virus-free production of high-quality adeno-associated virus vectors
Lila Drittanti, Christine Jenny, Karine Poulard, Anne Samba, Peggy Manceau, Nestor Soria, Nathalie Vincent, Olivier Danos, Manuel Vega
The Journal of Gene Medicine. Feb 2001, Vol. 3, No. 1: 59-71
CrossRef
Isolation of Highly Infectious and Pure Adeno-Associated Virus Type 2 Vectors with a Single-Step Gravity-Flow Column
Alberto Auricchio, Markus Hildinger, Erin O'Connor, Guang-Ping Gao, James M. Wilson
Human Gene Therapy. Jan 2001, Vol. 12, No. 1: 71-76
Abstract | Full Text PDF | Reprints & Permissions
Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV)
Catherine R. O'Riordan, Amy L. Lachapelle, Karen A. Vincent, Samuel C. Wadsworth
The Journal of Gene Medicine. Dec 2000, Vol. 2, No. 6: 444-454
CrossRef
Purification of Recombinant Adeno-Associated Virus Vectors by Column Chromatography and Its Performance in Vivo
Guangping Gao, Guang Qu, Michael S. Burnham, James Huang, Narendra Chirmule, Bindu Joshi, Qian-Chun Yu, Jonathan A. Marsh, Christina M. Conceicao, James M. Wilson
Human Gene Therapy. Oct 2000, Vol. 11, No. 15: 2079-2091
Abstract | Full Text PDF | Reprints & Permissions
Adeno-associated virus-based vectors in gene therapy
Jacov Tal
Journal of Biomedical Science. Aug 2000, Vol. 7, No. 4: 279-291
CrossRef
Adeno-Associated Virus Vectors Show Variable Dependence on Divalent Cations for Thermostability: Implications for Purification and Handling
Anne E. Turnbull, Anna Skulimowski, Jason A. Smythe, Ian E. Alexander
Human Gene Therapy. Mar 2000, Vol. 11, No. 4: 629-635
Abstract | Full Text PDF | Reprints & Permissions
Recombinant Adeno-Associated Virus-Mediated Correction of Lysosomal Storage within the Central Nervous System of the Adult Mucopolysaccharidosis Type VII Mouse
Thomas J. Sferra, Guang Qu, David McNeely, Rachel Rennard, K. Reed Clark, Warren D. Lo, Philip R. Johnson
Human Gene Therapy. Mar 2000, Vol. 11, No. 4: 507-519
Abstract | Full Text PDF | Reprints & Permissions
Progress in Adeno-Associated Virus Type 2 Vector Production: Promises and Prospects for Clinical Use
Dirk Grimm, Jurgen A. Kleinschmidt
Human Gene Therapy. Oct 1999, Vol. 10, No. 15: 2445-2450
Abstract | Full Text PDF | Reprints & Permissions
All articles
Previous Next
• Help with PDFs
• Add to favorites
• Email to a colleague
•  Reprints & Permissions
• Track citations
• Download metadata
•  TOC Alert
•  Citation Alert
    What is RSS?
• Most read articles
• Most cited articles

Recommend & Share

• CiteULike
• Delicious
• Digg This
• Facebook
• Newsvine


• 
• 
Related articles in:
Liebert Online

Search:
for
Authors:
K. Reed Clark
Xinglou Liu
John P. Mcgrath
Philip R. Johnson
Keyword:
Advanced Search